Metabolism of theophylline and its inhibition by fluoroquinolones in rat hepatic microsomes

References

• Anadón A., Martinez-Larrañaga M. R., Fernandez M. C., Diaz M. J., Bringar P. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats. Antimicrobial Agents and Chemotherapy 1990; 34: 2148–2151
   PubMed Web of Science ®Google Scholar
• Beckmann J., Elsåber W., Gundert-Remy U., Hertrampf R. Enoxacin—a potent inhibitor of theophylline metabolism. European Journal of Clinical Pharmacology 1987; 33: 227–230
   PubMed Web of Science ®Google Scholar
• Berthou F., Flinois J.-P., Ratanasavanh D., Beaune P., Riche C., Guillouzo A. Evidence for involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes. Drug Metabolism and Disposition 1991; 19: 561–567
   PubMed Web of Science ®Google Scholar
• Burke M. D., Mayer R. T. Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metabolism and Disposition 1974; 2: 583–587
   PubMed Web of Science ®Google Scholar
• Campbell M. E., Grant D. M., Inaba T., Kalow W. Biotransformation of caffeine, paraxanthine, theophylline and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes. Drug Metabolism and Disposition 1987; 15: 237–249
   PubMed Web of Science ®Google Scholar
• Davis J. D., Aarons L., Houston J. B. Relationship between enoxacin and ciprofloxacin plasma concentrations and theophylline disposition. Pharmaceutical Research 1994; 11: 1424–1428
   PubMed Web of Science ®Google Scholar
• Davis J. D., Aarons L., Houston J. B. Effect of norfloxacin on theophylline disposition: a comparison with other fluoroquinolones. Pharmaceutical Research 1995; 12: 257–262
   PubMed Web of Science ®Google Scholar
• Edwards D. J., Bowles S. K., Svensson C. K., Rybak M. M. Inhibition of drug metabolism by quinolone antibiotics. Clinical Pharmacokinetics 1988; 15: 194–204
   PubMed Web of Science ®Google Scholar
• Fuhr U., Strobl G., Manaut F., Anders E.-M., Sorgel F., Lopez-de-Brinas E., Chu D. T. W., Pernet A. G., Mahr G., Sanz F., Staib A. H. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2. Molecular Pharmacology 1992; 43: 191–199
   Web of Science ®Google Scholar
• Lake B. G. Preparation and characterization of microsomal fractions for studies of xenobiotic metabolism. Biochemical Toxicology—A Practical Approach, K. Snell, B. Mullock. IRL, Oxford 1987, chapter 8
   Google Scholar
• Lohmann S. M., Miech R. P. Theophylline metabolism by the rat liver microsomal system. Journal of Pharmacology and Experimental Therapeutics 1976; 196: 213–225
   PubMed Web of Science ®Google Scholar
• Matthew D. E., Houston J. B. Drug metabolizing capacity in vitro and in vivo. I. Correlations between hepatic microsomal monooxygenase markers in β-napthoflavone-induced rats. Biochemical Pharmacology 1990a; 40: 743–749
   PubMed Web of Science ®Google Scholar
• Matthew D. E., Houston J. B. Drug metabolizing capacity in vitro and in vivo. II. Correlations between hepatic microsomal monooxygenase markers in phenobarbital-induced rats. Biochemical Pharmacology 1990b; 40: 751–758
   PubMed Web of Science ®Google Scholar
• McManus M. E., Miners J. O., Gregor D., Stupans I., Birkett D. J. Theophylline metabolism by human, rabbit and rat liver microsomes and by purified forms of cytochrome P450. Journal of Pharmacy and Pharmacology 1988; 40: 388–391
   PubMed Web of Science ®Google Scholar
• Mizuki Y., Kamaura M., Yamaguchi T., Sekine Y., Hashimoto M. Interaction of enoxacin with theophylline in rats. Arzneimittel Forschung 1989; 39(5)593–597
   PubMed Web of Science ®Google Scholar
• Muir K. T., Kunitani M., Reigelman S. Improved HPLC assay for theophylline in plasma and saliva in the presence of caffeine and its metabolites and comparisons with three other assays. Journal of Chromatography 1982; 231: 73–81
   PubMed Web of Science ®Google Scholar
• Phillipson C. E., Godden P. M. M., Lum P. Y., Ioannides C., Park D. V. Determination of cytochrome P-448 activity in biological tissues. Biochemical Journal 1984; 221: 81–88
   PubMed Web of Science ®Google Scholar
• Rettie A. E., Korzekwa K. R., Kunze K. L., Lawrence R. F., Eddy A. C., Aoyama T., Gelboin H. V., Gonzalez F. J., Trager W. F. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chemical Research and Toxicology 1992; 5: 54–59
   PubMed Web of Science ®Google Scholar
• Robson R. A., Matthews A. P., Miners J. O., McManus M. E., Meyer U. A., Birkett D. J. Characterisation of theophylline metabolism in human liver microsomes. British Journal of Clinical Pharmacology 1987; 24: 293–300
   PubMed Web of Science ®Google Scholar
• Ryan D. E., Levin W. Purification and characterisation of hepatic microsomal cytochrome P450. Pharmacology and Therapeutics 1990; 45: 153–239
   PubMed Web of Science ®Google Scholar
• Sarkar M., Jackson B. J. Theophylline N-demethylations as probes for P4501A1 and P4501A2. Drug Metabolism and Diposition 1994; 22: 827–834
   PubMed Web of Science ®Google Scholar
• Sarkar M., Polk R. E., Guzelian P. S., Hunt C., Karnes H. T. In vitro effects of fluoroqunolones on theophylline metabolism in human liver microsomes. Antimicrobial Agents and Chemotherapy 1990; 34: 594–599
   PubMed Web of Science ®Google Scholar
• Thomas P. E., Reik L. M., Ryan D. E., Levin W. Induction of two immunochemically related rat liver cytochrome P450 isozymes, cytochromes P450c and P450d, by structurally diverse xenobiotics. Journal of Biological Chemistry 1983; 256: 4590–4598
   Google Scholar
• Toon S., Hopkins K. J., Garstang F. M., Aarons L., Sedman A., Rowland M. Enoxacin-warfarin intraction: pharmacokinetic and stereochemical aspects. Clinical Pharmacology and Therapeutics 1987; 42: 3341
   Web of Science ®Google Scholar
• Valero F., De La Torre R., Secura J. Selective in vitro inhibition of hepatic oxidative metabolism by quinolones: 7-ethoxyresorafin and caffeine as model substrates. Journal of Pharmacy and Pharmacology 1991; 43: 17–21
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochemical Journal 1992; 281: 577–592
   PubMed Web of Science ®Google Scholar
• Wijnands W. J. A., Trooster J. F. G., Teunissen P. C., Cats H. A., Vree T. B. Ciprofloxacin does not impair the elimination of diazepam in humans. Drug Metabolism and Disposition 1990; 18: 954–957
   PubMed Web of Science ®Google Scholar